Prairie Education and Research Cooperative Selects DataLabs as Exclusive Electronic Clinical Data Management Provider
World Renowned Cardiovascular Research Institute Selects DataLabsXC to Support and Conduct Clinical Trials for Testing of Cardiovascular Devices and Drugs
IRVINE, Calif. - June 20, 2005 - DataLabs, an innovative developer of Internet-based applications for clinical development, announced today that it has been selected as the exclusive provider of electronic clinical data management technology by the Prairie Education and Research Cooperative (PERC). The Springfield, Ill. based non-profit organization will use DataLabs technology to support and conduct clinical trials for the testing of devices and drugs in the cardiovascular field.
PERC conducted a thorough evaluation of multiple electronic clinical data management solutions over a two-month period. The evaluation focused on both the technical aspects and user acceptance of the software, in addition to finding a vendor with the best licensing business model for PERC's specified use cases.
"By utilizing the functionality of DataLabsXC, we hope to reduce costs by streamlining the data entry process and reducing errors," said Conrad Davis, PERC's senior database manager. "Having this technology offered via a web browser decreases the time needed to get a study up and running because software does not have to be installed on each individual workstation. We're very excited to make use of DataLabsXC's capabilities."
According to Davis, PERC selected DataLabs because of the following key factors:
- DataLabs was the only vendor to have a licensing business model which provides flexibility for expandability and scaling options.
- DataLabs' electronic clinical data management solution is intuitive and easy to use for study design, software management, and data collection.
- DataLabs technology promotes compatibility and easily integrates with PERC's existing technology systems.
- DataLabs solutions enable HIPAA compliance, are CDISC compatible, follow 21 CFR 11 standards, and have advanced audit trail capabilities.
As with many other leading academic research institutions, PERC conducts highly complex trials involving patients with multiple treatment paths. DataLabsXC, based on Microsoft platform technology, XML Web services, and the CDISC ODM standard, easily adapts to each institution's complex operating procedures and integrates easily with their existing technology systems. As a result, DataLabs is committed to providing PERC and the academic research world with clinical data management tools that will greatly enhance their clinical trial processes and accommodate all of their complex requirements.
"Prairie Education and Research Cooperative is one of the most highly regarded cardiovascular research institutions in the world," said Jim Langford, president of DataLabs, "Recognized for its excellence in clinical trial data collections and management, PERC continues to be at the forefront of conducting clinical trials by enhancing its current capabilities with DataLabs' technologies. The PERC-DataLabs relationship is another example of how DataLabsXC adds value for the academic research community."
About Prairie Education and Research Cooperative
Prairie Education Research Cooperative (PERC) was founded in 1983 as a non-profit organization dedicated to the advancement of cardiovascular medicine. PERC consists of a team of research staff and physicians who pursue excellence of patient care through clinical and basic scientific research. The group's research has been supported by National Institutes of Health, corporations, and several healthcare agencies. Results of numerous studies have been published in major publications, presented at prestigious meetings, and implemented in the clinical setting. PERC is based in Springfield, Ill. For more information, please visit www.prairieresearch.com www.prairieresearch.com.
About DataLabs
DataLabs is an innovative developer of Internet-based applications for clinical development that helps the biopharmaceutical industry accelerate clinical trials with proven software for study design, data capture and data management. Based on Microsoft platform technology, XML Web services and CDISC ODM standards, the DataLabsXC product suite adapts to established operating procedures and integrates easily with existing technology systems. As a result, DataLabsXC customers enjoy a low total cost of ownership and high return on investment. Major pharmaceutical companies, government entities, healthcare organizations and contract research organizations are currently realizing time and cost savings using DataLabsXC. DataLabs, a Microsoft Certified Partner, is based in Irvine, Calif. with an East Coast office in Pennsylvania. For more information, please visit www.datalabs.com www.datalabs.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
